Evidence map›Paper›PMID 24875054›Full record

ArticlePloS one2014

F-spondin deficient mice have a high bone mass phenotype.

Glyn D Palmer, Mukundan G Attur, Qing Yang, James Liu, Paxton Moon, Frank Beier, Steven B Abramson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Genetic Architecture of High Bone Mass.Frontiers in endocrinology · 2020
    Review
  10. Article
  11. Observational
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Glyn D PalmerDivision of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, New York, United States of America.
Mukundan G AtturDivision of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, New York, United States of America.
Qing YangDivision of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, New York, United States of America.
James LiuDivision of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, New York, United States of America.
Paxton MoonDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada.
Frank BeierDepartment of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, The University of Western Ontario, London, Ontario, Canada.
Steven B AbramsonDivision of Rheumatology, New York University School of Medicine and NYU Hospital for Joint Diseases, New York, New York, United States of America.
New York University Langone Orthopedic Hospital · USWestern University · CA

Funding

Regulation of chondrocytes by extracellular matrix protein.R01AR054817 · NIAMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ABRAMSON, STEVEN B · 2009 to 2014
$2.1M
NIAMS NIH HHS AR054817NIAMS NIH HHS R01 AR054817
6 · The paper itself

Abstract

F-spondin is a pericellular matrix protein upregulated in developing growth plate cartilage and articular cartilage during osteoarthritis. To address its function in bone and cartilage in vivo, we generated mice that were deficient for the F-spondin gene, Spon1. Spon1-/- mice were viable and developed normally to adulthood with no major skeletal abnormalities. At 6 months, femurs and tibiae of Spon1-/- mice exhibited increased bone mass, evidenced by histological staining and micro CT analyses, which persisted up to 12 months. In contrast, no major abnormalities were observed in articular cartilage at any age group. Immunohistochemical staining of femurs and tibiae revealed increased levels of periostin, alkaline phosphate and tartrate resistant acid phosphatase (TRAP) activity in the growth plate region of Spon1-/- mice, suggesting elevated bone synthesis and turnover. However, there were no differences in serum levels of TRAP, the bone resorption marker, CTX-1, or osteoclast differentiation potential between genotypes. Knockout mice also exhibited reduced levels of TGF-β1 in serum and cultured costal chondrocytes relative to wild type. This was accompanied by increased levels of the BMP-regulatory SMADs, P-SMAD1/5 in tibiae and chondrocytes. Our findings indicate a previously unrecognized role for Spon1 as a negative regulator of bone mass. We speculate that Spon1 deletion leads to a local and systemic reduction of TGF-β levels resulting in increased BMP signaling and increased bone deposition in adult mice.

Indexed as

PhenotypeAnimalsBiomarkersBone and BonesChondrocytesExtracellular Matrix ProteinsGene OrderGene TargetingGenotypeMiceMice, KnockoutOsteoclastsPhosphorylationSmad ProteinsTransforming Growth Factor betaX-Ray MicrotomographyBiomarkersExtracellular Matrix ProteinsF-spondin protein, mouseSmad ProteinsTransforming Growth Factor beta

Identifiers

PMID24875054
PMCPMC4038615
OpenAlexW2089806143

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.